Author:
Gu Yongquan,Cui Shijun,Wang Qi,Liu Changjian,Jin Bi,Guo Wei,Liu Changwei,Chu Tongbin,Shu Chang,Zhang Fuxian,Han Chengquan,Liu Yue
Funder
Beijing Northland Biotech., Co., Ltd., China
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference19 articles.
1. Inter-society consensus for the management of peripheral arterial disease (TASC II);Norgren;J. Vasc. Surg.,2007
2. Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelines;Mohler;Curr. Med. Res. Opin.,2008
3. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis;Fowkes;Lancet,2013
4. The current state of critical limb ischemia: a systematic review;Farber;JAMA Surg.,2016
5. Note for guidance on clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease. European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products (EMEA CPMP), April 25, 2002, CPMP/EWP/714/98. https://www.ema.europa.eu/en/documents/scientific-guideline/note-guidance-clinical-investigation-medicinal-products-treatment-peripheral-arterial-occlusive_en.pdf.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献